Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties.

Urs NM, Gee SM, Pack TF, McCorvy JD, Evron T, Snyder JC, Yang X, Rodriguiz RM, Borrelli E, Wetsel WC, Jin J, Roth BL, O'Donnell P, Caron MG.

Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):E8178-E8186. Epub 2016 Dec 1.

PMID:
27911814
2.

The neural underpinnings of cognitive flexibility and their disruption in psychotic illness.

Waltz JA.

Neuroscience. 2017 Mar 14;345:203-217. doi: 10.1016/j.neuroscience.2016.06.005. Epub 2016 Jun 7. Review.

PMID:
27282085
3.

Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression.

Grace AA.

Nat Rev Neurosci. 2016 Aug;17(8):524-32. doi: 10.1038/nrn.2016.57. Epub 2016 Jun 3. Review.

4.

Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model.

Gomes FV, Rincón-Cortés M, Grace AA.

Neurosci Biobehav Rev. 2016 Nov;70:260-270. doi: 10.1016/j.neubiorev.2016.05.030. Epub 2016 May 24. Review.

PMID:
27235082
5.

Mild Reinforcement Learning Deficits in Patients With First-Episode Psychosis.

Chang WC, Waltz JA, Gold JM, Chan TC, Chen EY.

Schizophr Bull. 2016 Nov;42(6):1476-1485. Epub 2016 May 13.

PMID:
27179125
6.
7.

Dopamine System Dysregulation and the Pathophysiology of Schizophrenia: Insights From the Methylazoxymethanol Acetate Model.

Grace AA.

Biol Psychiatry. 2017 Jan 1;81(1):5-8. doi: 10.1016/j.biopsych.2015.11.007. Epub 2015 Nov 17. No abstract available.

PMID:
26705848
8.

Social Stress and Psychosis Risk: Common Neurochemical Substrates?

Mizrahi R.

Neuropsychopharmacology. 2016 Feb;41(3):666-74. doi: 10.1038/npp.2015.274. Epub 2015 Sep 9. Review.

9.

Advances in imaging ultrastructure yield new insights into presynaptic biology.

Bruckner JJ, Zhan H, O'Connor-Giles KM.

Front Cell Neurosci. 2015 May 22;9:196. doi: 10.3389/fncel.2015.00196. eCollection 2015. Review.

10.

Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study.

Kumari V, Ettinger U, Lee SE, Deuschl C, Anilkumar AP, Schmechtig A, Corr PJ, Ffytche DH, Williams SC.

Psychopharmacology (Berl). 2015 Sep;232(17):3135-47. doi: 10.1007/s00213-015-3959-1. Epub 2015 May 19.

11.

Glutamate Decarboxylase 67 Deficiency in a Subset of GABAergic Neurons Induces Schizophrenia-Related Phenotypes.

Fujihara K, Miwa H, Kakizaki T, Kaneko R, Mikuni M, Tanahira C, Tamamaki N, Yanagawa Y.

Neuropsychopharmacology. 2015 Sep;40(10):2475-86. doi: 10.1038/npp.2015.117. Epub 2015 Apr 23.

12.

Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.

Slifstein M, van de Giessen E, Van Snellenberg J, Thompson JL, Narendran R, Gil R, Hackett E, Girgis R, Ojeil N, Moore H, D'Souza D, Malison RT, Huang Y, Lim K, Nabulsi N, Carson RE, Lieberman JA, Abi-Dargham A.

JAMA Psychiatry. 2015 Apr;72(4):316-24. doi: 10.1001/jamapsychiatry.2014.2414.

13.

Behavioral effects of the benzodiazepine-positive allosteric modulator SH-053-2'F-S-CH₃ in an immune-mediated neurodevelopmental disruption model.

Richetto J, Labouesse MA, Poe MM, Cook JM, Grace AA, Riva MA, Meyer U.

Int J Neuropsychopharmacol. 2015 Jan 30;18(4). pii: pyu055. doi: 10.1093/ijnp/pyu055.

14.

An Overview of the Association between Schizotypy and Dopamine.

Mohr C, Ettinger U.

Front Psychiatry. 2014 Dec 19;5:184. doi: 10.3389/fpsyt.2014.00184. eCollection 2014. Review.

15.

Neurophysiological effects of acute oxytocin administration: systematic review and meta-analysis of placebo-controlled imaging studies.

Wigton R, Radua J, Allen P, Averbeck B, Meyer-Lindenberg A, McGuire P, Shergill SS, Fusar-Poli P.

J Psychiatry Neurosci. 2015 Jan;40(1):E1-22. Review.

16.

Reinforcement learning deficits in people with schizophrenia persist after extended trials.

Cicero DC, Martin EA, Becker TM, Kerns JG.

Psychiatry Res. 2014 Dec 30;220(3):760-4. doi: 10.1016/j.psychres.2014.08.013. Epub 2014 Aug 15.

17.

New approaches to the management of schizophrenia: focus on aberrant hippocampal drive of dopamine pathways.

Perez SM, Lodge DJ.

Drug Des Devel Ther. 2014 Jul 2;8:887-96. doi: 10.2147/DDDT.S42708. eCollection 2014. Review.

18.

Vagal nerve stimulation reverses aberrant dopamine system function in the methylazoxymethanol acetate rodent model of schizophrenia.

Perez SM, Carreno FR, Frazer A, Lodge DJ.

J Neurosci. 2014 Jul 9;34(28):9261-7. doi: 10.1523/JNEUROSCI.0588-14.2014.

19.

Alterations in dopamine system function across the estrous cycle of the MAM rodent model of schizophrenia.

Perez SM, Chen L, Lodge DJ.

Psychoneuroendocrinology. 2014 Sep;47:88-97. doi: 10.1016/j.psyneuen.2014.05.005. Epub 2014 May 14.

20.

Mechanisms Underlying Auditory Hallucinations-Understanding Perception without Stimulus.

Tracy DK, Shergill SS.

Brain Sci. 2013 Apr 26;3(2):642-69. doi: 10.3390/brainsci3020642.

Supplemental Content

Support Center